The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of "“Augmenting human gamma delta lymphocytes for cancer therapy with chimeric antigen receptors”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2023 |
Marzieh Mazinani, Fatemeh Rahbarizadeh. New cell sources for CAR-based immunotherapy, Biomarker Research. 2023; 11: 49. https://doi.org/10.1186/s40364-023-00482-9 |
|
2 |
2023 |
Mohammad Reza Lahimchi, Faezeh Maroufi, Amirhosein Maali. Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor T Cells: The Intersection of Stem Cells and Immunotherapy, Cellular Reprogramming. 2023; 25: 195. https://doi.org/10.1089/cell.2023.0041 |
|
3 |
2025 |
John Anderson, 2025; 77. https://doi.org/10.1016/B978-0-443-21766-1.00009-6 |
|
4 |
2024 |
Claudia Juraske, Sonia M Krissmer, Evelyn S Teuber, Maria A Parigiani, Juliane Strietz, Daniela Wesch, Dieter Kabelitz, Susana Minguet, Wolfgang W Schamel. Reprogramming of human γδ T cells by expression of an anti-CD19 TCR fusion construct (εTRuC) to enhance tumor killing, Journal of Leukocyte Biology. 2024; 115: 293. https://doi.org/10.1093/jleuko/qiad128 |
|
5 |
2024 |
Chaozhi Tang, Yuling Zhang. Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review, Pathology - Research and Practice. 2024; 262: 155518155518. https://doi.org/10.1016/j.prp.2024.155518 |